Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Capita secures three-year extension to ScottishPower partnership

(Sharecast News) - Professional services firm Capita said on Friday that its Contact Centre subdivision has secured a three-year extension to its partnership with ScottishPower for an undisclosed sum. Capita said the contract extension, which builds on a relationship that began in 2022, will see it continue to deliver five key work packages across prepayment, homemover, SME, smart meter, and direct debit, each "critical" to ScottishPower's service delivery.

As part of the extension, services will transition to Capita's flagship delivery hub at Mutual Park in Cape Town - its largest global site. It also will collaborate with ScottishPower to harness the power of CCAi, its proprietary generative AI platform, with the joint effort focused on optimising service performance and enhancing customer outcomes.

"This extension reflects ScottishPower's confidence in our ability to deliver consistent, high-quality service," said Corinne Ripoche, CEO of Capita Experience. "We look forward to continuing our collaboration with ScottishPower and delivering value through innovation, efficiency, and customer-centric service."

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.